Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype

Mov Disord. 2011 Jul;26(8):1558-60. doi: 10.1002/mds.23564. Epub 2011 Apr 4.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Carbidopa / therapeutic use
  • DNA Mutational Analysis
  • Drug Combinations
  • Female
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Infant
  • Levodopa / therapeutic use
  • Movement Disorders / cerebrospinal fluid
  • Movement Disorders / drug therapy
  • Movement Disorders / genetics*
  • Movement Disorders / physiopathology
  • Phenotype*
  • Sequence Deletion / genetics*
  • Tyrosine 3-Monooxygenase / genetics*
  • Video Recording

Substances

  • Antiparkinson Agents
  • Drug Combinations
  • carbidopa, levodopa drug combination
  • Levodopa
  • Tyrosine 3-Monooxygenase
  • Carbidopa
  • Homovanillic Acid